| D011452 |
15-Oxoprostaglandin 13-Reductase |
(5Z)-(15S)-11 alpha-Hydroxy-9,15-dioxoprostanoate:NAD(P)+ delta(13)-oxidoreductase. An enzyme active in prostaglandin E and F catabolism. It catalyzes the reduction of the double bond at the 13-14 position of the 15-ketoprostaglandins and uses NADPH as cofactor. EC 1.3.1.48. |
Prostaglandin delta-13-Reductase,Prostaglandin-13,14-Reductase,15-Ketoprostaglandin delta 13-Reductase,delta 13-15-Ketoprostaglandin Reductase,delta-13-PG-Reductase,13-15-Ketoprostaglandin Reductase, delta,13-Reductase, 15-Ketoprostaglandin delta,13-Reductase, 15-Oxoprostaglandin,15 Ketoprostaglandin delta 13 Reductase,15 Oxoprostaglandin 13 Reductase,Prostaglandin 13,14 Reductase,Prostaglandin delta 13 Reductase,Reductase, delta 13-15-Ketoprostaglandin,delta 13 15 Ketoprostaglandin Reductase,delta 13 PG Reductase,delta 13-Reductase, 15-Ketoprostaglandin,delta-13-Reductase, Prostaglandin |
|
| D011453 |
Prostaglandins |
A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. |
Prostaglandin,Prostanoid,Prostanoids |
|
| D011458 |
Prostaglandins E |
(11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. |
PGE |
|
| D011460 |
Prostaglandins F |
(9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. |
PGF |
|
| D011463 |
Prostaglandins H |
A group of physiologically active prostaglandin endoperoxides. They are precursors in the biosynthesis of prostaglandins and thromboxanes. The most frequently encountered member of this group is the prostaglandin H2. |
|
|
| D011651 |
Pulmonary Artery |
The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs. |
Arteries, Pulmonary,Artery, Pulmonary,Pulmonary Arteries |
|
| D004373 |
Ductus Arteriosus |
A fetal blood vessel connecting the pulmonary artery with the descending aorta. |
Arteriosus, Ductus |
|
| D000818 |
Animals |
Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. |
Animal,Metazoa,Animalia |
|
| D000831 |
Animals, Newborn |
Refers to animals in the period of time just after birth. |
Animals, Neonatal,Animal, Neonatal,Animal, Newborn,Neonatal Animal,Neonatal Animals,Newborn Animal,Newborn Animals |
|
| D001011 |
Aorta |
The main trunk of the systemic arteries. |
Aortas |
|